75693-75-3

Usage

Uses

Used in Pharmaceutical Industry:
3-(3-cyclohexyl-3-hydroxypropyl)-2,5-dioxoimidazolidine-4-heptanoic acid is used as a pharmaceutical compound for its potential therapeutic properties. The unique structure of this molecule may allow it to interact with specific biological targets, making it a candidate for the development of new drugs.
Used in Chemical Synthesis:
In the field of chemical synthesis, 3-(3-cyclohexyl-3-hydroxypropyl)-2,5-dioxoimidazolidine-4-heptanoic acid can be used as a building block or intermediate for the synthesis of more complex molecules. Its unique structure may provide new opportunities for the creation of novel compounds with various applications.
Used in Material Science:
3-(3-cyclohexyl-3-hydroxypropyl)-2,5-dioxoimidazolidine-4-heptanoic acid may also find applications in material science, where its unique structure could be utilized to develop new materials with specific properties. For example, it could be used to create new polymers or coatings with improved characteristics.

InChI:InChI=1/C19H32N2O5/c22-16(14-8-4-3-5-9-14)12-13-21-15(18(25)20-19(21)26)10-6-1-2-7-11-17(23)24/h14-16,22H,1-13H2,(H,23,24)(H,20,25,26)

Upstream product

• 65705-50-2 diethyl 2-aminononanedioate 
• 590-28-3 potassium cyanate 
• 73487-97-5 (+/-)-diethyl 2-(3-cyclohexyl-3-hydroxypropylamino)nonanedioate hydrochloride 
• 73487-97-5 (+/-)-diethyl 2-(3-cyclohexyl-3-hydroxypropylamino)nonanedioate hydrochloride 
• 2177-34-6 1-cyclohexylprop-2-en-1-one 
• 73487-92-0 diethyl 2-ureidononanedioate 
• 73487-93-1 7-(2,5-dioxo-imidazolidin-4-yl)-heptanoic acid ethyl ester 

Downstream Products

• 73490-29-6 1-(3-cyclohexyl-3-hydroxy-propyl)-5-(7-hydroxy-heptyl)-imidazolidine-2,4-dione 
• 72814-29-0 7-[3-(3-cyclohexyl-3-hydroxy-propyl)-2,5-dioxo-imidazolidin-4-yl]-heptanoic acid ethyl ester 
• 73490-09-2 (+/-)-3-(3-cyclohexyl-3-oxopropyl)-2,5-dioxo-4-imidazolidineheptanoic acid 

Relevant academic research and scientific papers

Heterocyclic Prostaglandin Analogues. Part 3. The Relationship of Configuration to Biological Activity for Some Hydantoin Prostanglandin Analogues

The enantiomers of the two diastereomers of 5-(6-carboxyhexyl)-1-(3-cyclohexyl-3-hydroxypropyl)hydantoin have been synthesised.Potent inhibition of platelet aggregation in this series is associated with the configuration corresponding to that in the natural inhibitors, such as prostaglandins E1 and D2.

Nitrogen heterocycles

Hydantoins of formula (I) STR1 ps have biological properties related to those of naturally occurring prostaglandins and may be used in medicine, for example in the treatment of thrombosis.

Heterocyclic Prostaglandin Analogues. Part 2. Hydantoins and Other Imidazole Analogues

The stable hydantoin prostaglandin analogues (2b) and (3b) have been synthesised as racemic compounds.The less polar diastereoisomer of (2b) is a potent inhibitor of platelet aggregation in human platelet-rich plasma and its cyclohexyl analogue (22, R = C6H11) has ca. 14 times the potency of prostaglandin E1 in this test coupled with selectivity of biological action.Other structural modifications such as introduction of a 15-methyl group and insertion of the m-phenylene or m-oxaphenylene moieties into the acid side-chain of (2b) led to a reduction in anti-aggregatory potency.Synthesis of the imidazole (41) is described.